Overactive bladder and sleep disturbance have a significant effect on indoor falls: results from the community health survey in Japan - Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
OBJECTIVES: To evaluate the effect of overactive bladder (OAB) and frailty on indoor fall events in community-dwelling adults aged 50 or older. METHODS: We conducted a cross-sectional study involving 723 adults between 2016 and 2017 in Hirosaki, Japan.... (Source: SafetyLit)
Source: SafetyLit - June 11, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Granules India gets USFDA nod for overactive bladder treatment capsule
"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wholly owned foreign subsidiary of Granules India Ltd, for Trospium Chloride extended-release capsules, 60 mg," the company said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 24, 2020 Category: Pharmaceuticals Source Type: news

Fall/fracture-related healthcare costs and their association with cumulative anticholinergic burden in people with overactive bladder - Lozano-Ortega G, Schermer CR, Walker DR, Szabo SM, Rogula B, Deighton AM, Gooch KL, Campbell NL.
BACKGROUND: Falls/fractures are major causes of morbidity and mortality among older adults and the resulting health consequences generate a substantial economic burden. Risk factors are numerous and include overactive bladder (OAB) and anticholinergic use.... (Source: SafetyLit)
Source: SafetyLit - April 22, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Inpatient'Voiding School' Could Boost Continence in Kids With Refractory Non-neurogenic Overactive Bladder Inpatient'Voiding School' Could Boost Continence in Kids With Refractory Non-neurogenic Overactive Bladder
An inpatient bladder rehabilitation"voiding school" appears to improve day- and night-time incontinence in children with refractory non-neurogenic overactive bladder, researchers from Belgium report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

New clinical trial examines a potential noninvasive solution for overactive bladders
(University of Southern California - Health Sciences) Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions, such as a spinal cord injury or stroke, and idiopathic (unknown) causes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 10, 2020 Category: International Medicine & Public Health Source Type: news

Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder
IRVINE, Calif.& BASEL, Switzerland--(BUSINESS WIRE) March 5, 2020 -- Urovant Sciences (Nasdaq: UROV) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 5, 2020 Category: Drugs & Pharmacology Source Type: news

Millions with bladder weakness may finally be spared embarrassment thanks to 'game-changer' test
Scientists at the University of Portsmouth are a step closer in the development of a 'game-changer' test which will diagnose an overactive bladder quicker, slowing the condition's progression. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2020 Category: Consumer Health News Source Type: news

Wireless device for treating people with overactive bladder
People with an overactive bladder could have a rechargeable wireless device fitted to ease their condition, NICE has said in new draft guidance. (Source: NHS Networks)
Source: NHS Networks - February 18, 2020 Category: UK Health Source Type: news

Ease drug-resistant overactive bladder with wireless device, doctors advised
Can be inserted under skin to stimulate sacral nerve, says NICE Related items fromOnMedica Surgical mesh last resort for prolapse or incontinence Pelvic organ prolapse Strong women ’s rights linked to better health Hundreds of women take legal action over vaginal mesh implants Surgical options must be ‘last resort’ for stress incontinence (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 14, 2020 Category: UK Health Source Type: news

Drug activates brown fat, improves glucose metabolism in healthy women
In a small study, a drug approved to treat overactive bladder boosted brown fat activity and improved glucose metabolism in healthy women. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 4, 2020 Category: Consumer Health News Source Type: news

Developing a Nurse Practitioner-Directed OAB Program Developing a Nurse Practitioner-Directed OAB Program
Could an NP-led program help streamline the management of patients with overactive bladder?Urologic Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 29, 2020 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

ANI Announces Launch of Tolterodine Extended-Release Capsules
BAUDETTE, Minn., Jan. 24, 2020 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Tolterodine Extended-Release Capsules, 2 mg and 4 mg. The current annual U.S. market for... Biopharmaceuticals, Urology, Generics, Product Launch ANI Pharmaceuticals, Tolterodine, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2020 Category: Pharmaceuticals Source Type: news

Bioelectronic Medicine on the Rise
Bioelectronic medicine could be one of healthcare’s biggest secrets. The space is filled with applications – but many aren’t mainstream yet. A panel titled “ Bioelectronic Medicine: Redefining Medical Treatment,” will be held Tuesday, February 11, from 2:05 to 3:00 p.m. in Room 210A at MD&M West Anaheim to discuss the space and how it could impact healthcare. While there have been some significant movements in that time – perhaps one of the greatest has developments has been GlaxoSmithKline teaming up with Verily...
Source: MDDI - January 22, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Electronics Source Type: news

Using Neuromodulation to Treat Premature Ejaculation
Men’s sexual health and wellness company, Morari Medical is using neuromodulation for its wearable device to help treat premature ejaculation (PE). The Maple Grove, MN-based company debuted a prototype of the patch-like device at the Consumer Electronics Show in Las Vegas earlier this month. Morari was one of 10 companies in the emerging sextech market to have a presence at the show. Jeff Bennett, the company’s founder and CEO spoke with MD+DI about the Morari Medical and its mission. “Specifically, we’re trying to address the medical condition of PE, ...
Source: MDDI - January 20, 2020 Category: Medical Devices Authors: Omar Ford Tags: Electronics Source Type: news

What Works Best to Help Men With Overactive Bladder?
Title: What Works Best to Help Men With Overactive Bladder?Category: Health NewsCreated: 1/14/2020 12:00:00 AMLast Editorial Review: 1/15/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 15, 2020 Category: Nutrition Source Type: news

What Works Best to Help Men With Overactive Bladder?
A combination of drugs and behavioral therapy seems to work better than drugs alone, but behavioral therapy alone also worked better than drugs, the researchers found. (Source: WebMD Health)
Source: WebMD Health - January 14, 2020 Category: Consumer Health News Source Type: news

What Works Best to Help Men With Overactive Bladder?
TUESDAY, Jan. 14, 2020 -- Learning how to control the urge to urinate may be all the therapy men need to treat an overactive bladder, a new study suggests. A combination of drugs and behavioral therapy seems to work better than drugs alone, but... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 14, 2020 Category: General Medicine Source Type: news

Medtronic Wins CE Mark for Rechargeable Sacral Neuromodulation Tech
The sacral neuromodulation market continues to see disruption as Medtronic scores a CE mark for its InterStim Micro neurostimulator and InterStim SureScan MRI leads, clearing the technologies for sale in Europe. InterStim Micro is a rechargeable device that delivers sacral neuromodulation (SNM) therapy to treat overactive bladder (OAB), fecal incontinence (FI) and non-obstructive urinary retention. It is 80% smaller than the existing recharge-free InterStim II neurostimulator and could reduce the need for battery replacement surgeries due to its life of 15 years. It also features Medtronic'sÂ&...
Source: MDDI - January 14, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Behavioral Therapy First Step for Overactive Bladder in Men
MONDAY, Jan. 13, 2020 -- Among men with overactive bladder, combined behavioral and drug therapy is superior to drug therapy alone, but not behavioral therapy alone, for symptomatic improvement, according to a study published online Jan. 13 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2020 Category: Pharmaceuticals Source Type: news

Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dec. 30, 2019-- Urovant Sciences (Nasdaq: UROV) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 30, 2019 Category: Drugs & Pharmacology Source Type: news

20 Private Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

20 Private Medtech Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

MD+DI Readers Rally Behind Axonics for Company of the Year
Last week MD+DI announced Zimmer Biomet as our editors' choice for 2019 Medtech Company of the Year for its impressive turnaround efforts. But as much as we enjoy recognizing our choice each year, it's always fun to see which company is the favorite among our readership. Out of a whopping 2,651 readers who responded to this year's survey, 45.34% (1,202) voted for Axonics Modulation Technologies out of the 10 finalists. Indeed, 2019 was a critical year for Axonics as it won FDA approval for two indications of its implantable rechargeable sacral neuromodulation&Acir...
Source: MDDI - December 20, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Medtech in a Minute: Hologic & #039;s Cynosure Flop, Axonics Stands Its Ground, and More
Axonics Not Intimidated by Medtronic Axonics' implantable rechargeable sacral neuromodulation device is now FDA-approved for the treatment of fecal incontinence, overactive bladder, and urinary retention. Medtronic is suing Axonics for alleged patent infringement, but the company does not appear to be intimidated.   Thermo Fisher May Fancy Qiagen The rumor mill was lit with a recent Bloomberg report of a potential $8 billion Thermo Fisher-Qiagen deal. Qiagen acknowledged that it has received several "indications of interest" but t...
Source: MDDI - November 22, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Axonics Isn & #039;t Letting Medtronic Stand in Its Way
For 22 years, the world's largest pure-play medical device company was the only player in sacral neuromodulation, a space that addresses urinary problems as well as fecal incontinence. Now there's a new kid on the block, which has created quite an intense David vs. Goliath medtech story. For those unfamiliar with the Axonics vs. Medtronic story up to this point, click here for a quick rundown of recent events that have transpired in this market.   FDA Approves Second Indication for Axonics r-SNM FDA approved the urinary indications for an implantable rechargeable sacral neuro...
Source: MDDI - November 18, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news

Urinary Incontinence & OAB | Medscape Urinary Incontinence & OAB | Medscape
Review in-depth clinical information, latest medical news, and guidelines on urinary incontinence, urge incontinence, and adult incontinence. Read about overactive bladder (OAB) and overactive bladder treatment. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 12, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Cadence Raises $15M in a Healthy and Growing Neuromodulation Market
Cadence Neuroscience is moving to bring a neuromodulation therapy for patients with focal drug-resistant epilepsy to market. The Redmond, WA-based company has raised $15 million in a series A round to help with this goal. Cadence’s financing round was led by JAZZ Venture Partners, with additional support being provided by Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the Epilepsy Foundation of America (EFA). The device was developed by a Mayo Clinic, Rochester campus Neurology and Neurosurgery team. Cadence is licensing the technology from Mayo and said the device uses chronic subthreshold...
Source: MDDI - November 6, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Medtronic Sues Axonics for Patent Infringement
The medical device industry has seen its share of David vs. Goliath stories over the years, but few have been as intense as the battle between Medtronic and Axonics over the sacral neuromodulation (SNM) market. The story took an unexpected turn this week as Medtronic slapped Axonics with a patent infringement lawsuit that is likely to take years to play out. Medtronic (the Goliath of this story), filed a lawsuit against Axonics Modulation Technologies (the David of the story), alleging infringement of four patents related to Medtronic's SNM lead placement procedure and implant recharging technologie...
Source: MDDI - November 5, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Implants Source Type: news

Medtronic and Axonics Go Toe-to-Toe in Fast-Growing Sacral Neuromodulation Market
Medtronic and Axonics are getting ready to square off in sacral neuromodulation, a fast-growing market that was monopolized by Medtronic until a month ago. Last month, Axonics won FDA approval to market its implantable rechargeable sacral neuromodulation (r-SNM) device for the treatment of fecal incontinence, and the company is expected to get FDA approval for overactive bladder and urinary retention any time now. The fecal incontinence approval includes the claim of a 15-year functional life and the ability of patients to undergo full-body MRI scans without the necessity of having the device explanted. Medtron...
Source: MDDI - October 8, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

DR ELLIE CANNON: Desperate to avoid constant trips to the loo at night? 
DR ELLIE CANNON: For both men and women, overactive bladder syndrome can occur - when the muscle contracts involuntarily, even when the bladder isn't full. (Source: the Mail online | Health)
Source: the Mail online | Health - September 28, 2019 Category: Consumer Health News Source Type: news

Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladder
The approved product is a generic version of Vesicare tablets of Astellas Pharma US, Inc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 27, 2019 Category: Pharmaceuticals Source Type: news

Korean researchers find that moxa can effectively treat overactive bladder
(Natural News) Moxibustion is an age-old external treatment used in traditional Chinese medicine. It involves the burning of dried herbs like mugwort or wormwood on top of an acupuncture needle or over a layer of ginger or salt placed on the skin. Based on a bibliometric analysis on studies conducted from 1954 to 2007 in... (Source: NaturalNews.com)
Source: NaturalNews.com - September 19, 2019 Category: Consumer Health News Source Type: news

Axonics Takes on Medtronic in Sacral Neuromodulation for Bowel and Bladder Control
This article really demonstrated and did a very nice job in separating out the different types of anticholinergic medications and, specifically, the anticholinergic medications to treat overactive bladder, which is the primary pharmacological intervention that we have," Noblett said. The researchers analyzed the data by type of burden and level of burden (low, medium, high) and found that the risk of dementia, even in the low burden, went up by 19% and in the high burden was up by 60%.  "And those were just for patients with the overactive bladder anticholinergic,&q...
Source: MDDI - September 4, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Gait speed and overactive bladder in the healthy community-dwelling super elderly: the Sukagawa Study - Omae K, Yamamoto Y, Kurita N, Takeshima T, Naganuma T, Takahashi S, Ohnishi T, Ito F, Yoshioka T, Fukuhara S.
The objective of this study is to assess the association of muscle mass, grip strength, and gait speed with overactive bladder (OAB) in community-dwelling elderly adults. METHODS: This cross-sectional study was based on the data collected from... (Source: SafetyLit)
Source: SafetyLit - August 26, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Antidepressants linked to dementia: Mental meds may just trade one condition for another
(Natural News) Antidepressants and antihistamines are among the most common types of medications people take, and they belong to a class of drugs known as anticholinergics. These drugs can treat a variety of health problems, including COPD, asthma, depression, dizziness, gastrointestinal problems, overactive bladder, and the symptoms of Parkinson’s. Although they can be effective, a... (Source: NaturalNews.com)
Source: NaturalNews.com - July 16, 2019 Category: Consumer Health News Source Type: news

FemPulse Enrolls 1st Patient in Feasibility Study for OAB in Women
FemPulse is looking to make an impact in the bioelectronic medicine market with therapy for the personalized treatment of overactive bladder (OAB) in women.  The Minneapolis-based company said the first participant had been enrolled in a feasibility study evaluating physiological responses to therapy delivered with the FemPulse System. Observations from this feasibility study can further help elucidate the mechanisms of action and facilitate tailoring treatment plans for individual patients.  The clinical trial is an open-label, single-group assignment. Participants will wear a FemPulse ...
Source: MDDI - July 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Electronics Source Type: news

These common drugs may increase dementia risk
Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 25, 2019 Category: Neurology Tags: Alzheimer's / Dementia Source Type: news

Medical News Today: These common drugs may increase dementia risk
Drugs that doctors often use in the treatment of overactive bladder, gastrointestinal conditions, and depression may increase dementia risk by almost half. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 25, 2019 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Alembic Pharma gets USFDA nod for overactive bladder treatment drug
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2019 Category: Pharmaceuticals Source Type: news

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study - Szabo SM, Gooch K, Schermer C, Walker D, Lozano-Ortega G, Rogula B, Deighton A, Vonesh E, Campbell N.
OBJECTIVE: To estimate the association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder (OAB). DESIGN: A retrospective claims-based study (2007-2015) of patients with OAB; outcomes from a subset ... (Source: SafetyLit)
Source: SafetyLit - May 9, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Re: the association between overactive bladder and falls and fractures: a systematic review - Wein AJ.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - April 29, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Finally, a Wearable Neuromodulation Device for Overactive Bladder
As a urogynecology surgeon, Alexandra Haessler, MD, has seen firsthand the limitations of current overactive bladder (OAB) therapies. Aside from medication, the current gold standard for OAB is Medtronic's InterStim, an implantable sacral neuromodulation device that is FDA approved for the treatment of OAB as well as chronic fecal incontinence, and non-obstructive urinary retention. Haessler told MD+DI that the InterStim device works very well but it's an expensive treatment and access is limited because only a few subspecialists in any one metropolitan area are truly qualified to deliver the therapy. The InterStim is not ...
Source: MDDI - April 19, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug
The product will be manufactured at the group's manufacturing facility at SEZ in Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 2, 2019 Category: Pharmaceuticals Source Type: news

Even younger nightshift workers shown to need to pee more, worsening quality of life
(European Association of Urology) Millions of people work nights, but increasingly scientists are finding that night work is associated with health problems. Now a group of Italian scientists has found that nightshift workers also need to pee more, leading to a deteriorating quality of life for many workers, including care workers. This is also true of younger subjects, who would not normally be expected to report an overactive bladder. This work is reported at the European Association of Urology Congress in Barcelona. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 15, 2019 Category: International Medicine & Public Health Source Type: news

Bioness StimRouter(R) Neuromodulation System Receives European CE Mark Approval for the Treatment of Overactive Bladder (OAB)
FDA-Approved StimRouter Continues to Improve the Lives of Chronic Pain Patients in the United States VALENCIA, Calif., Feb. 19, 2019 -- (Healthcare Sales & Marketing Network) -- Bioness, Inc., the leading provider of state-of-the-art, clinically suppor... Devices, Neurology, Urology, Regulatory Bioness, StimRouter, Neuromodulation, Overactive Bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2019 Category: Pharmaceuticals Source Type: news

A Novel Tibial Nerve Stimulation Device for OAB A Novel Tibial Nerve Stimulation Device for OAB
Could this ambulatory transcutaneous tibial nerve stimulation device be an effective treatment option for patients with overactive bladder?Translational Andrology and Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 25, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Light-up 'belt' that shines on the bladder could stop embarrassing leaks
The surgically implanted device is designed to combat overactive bladder — which affects around eight million people in Britain. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2019 Category: Consumer Health News Source Type: news

Closed-loop device uses light to control overactive bladder
Researchers developed this small device implanted around the bladder of a rat to provide closed-loop bladder control. It uses light signals from tiny LEDs to activate nerve cells in the bladder. (Image courtesy of Gereau Lab, Washington University) A team of neuroscientists and engineers has developed a tiny, implantable, closed-loop device that may replace medication or electronic stimulators for bladder disorders. The team from Washington University School of Medicine in St. Louis, the University of Illinois at Urbana-Champaign, and the Feinberg School of Medicine at Northwestern University in Chicago created a soft, imp...
Source: Mass Device - January 7, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Neuromodulation/Neurostimulation News Well Research & Development Urology feinbergschoolofmedicineatnorthwesternuniversity University of Illinois at Urbana-Champaign Washington University School of Medicine Source Type: news

Risk of 4 Pelvic Floor Disorders Associated With Delivery Mode (CME/CE)
(MedPage Today) -- Lower risk of stress urinary incontinence, overactive bladder, and pelvic organ prolapse with cesarean delivery than with surgical and non-surgical vaginal births (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 23, 2018 Category: OBGYN Source Type: news

Incontinence Drug May Help Ease Severe Hot Flashes
Oxybutynin, a drug widely used to treat urinary incontinence caused by an overactive bladder, helps treat hot flashes in breast cancer survivors and women who did not have breast cancer but who were bothered by frequent or severe menopausal symptoms, new research shows. (Source: WebMD Health)
Source: WebMD Health - December 17, 2018 Category: Consumer Health News Source Type: news